Customer Guest RE-KYC
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
Pursuant to SEBI circular Eiko Lifesciences Ltd is not a Large Corporate. Hence filing of initial and annual disclosure does not arise.more...
As of March 2025 36.23% is owned by Indian Promoters and 63.77% by Public. Top five Promoters holding highest number of shares of Eiko Lifes...more...
Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations 2018more...
The company has taken note of appointment of Mr. Rajkumar Govindas Baheti (DIN: 05164182) an Independent Director of the Eiko Lifesciences L...more...
Pursuant to reg 47 & 30 of SEBI (LODR) Financial Results for quarter and nine months ended 31st December 2024 has been published in Financial Express...more...
The company reported standalone net profit of Rs 0.28 crore for the quarter ended December 31 2024 as compared to Rs 0.24 crore in the same ...more...
Integrated Financials for quarter and nine months ended 31st December 2024more...
Nil statement of Deviation for quarter and nine months ended 31st December 2024more...
Financial Results for Quarter and nine months ended 31st December 2024more...
Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 20...more...
As of January 2025 31.27% is owned by Indian Promoters and 68.73% by Public. Top five Promoters holding highest number of shares of Eiko Lifesciences...more...
As of January 2025 31.27% is owned by Indian Promoters and 68.73% by Public. Top five Promoters holding highest number of shares of Eiko Lif...more...
Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and...more...
The Right Issue Committee meeting held on 24.01.2025 discussed and approved on the matters as mentioned in the attachment.\r\n \r\nThe meeti...more...
As of December 2024 31.27% is owned by Indian Promoters and 68.73% by Public. Top five Promoters holding highest number of shares of Eiko Lifescience...more...
Certificate u/r 74(5) of SEBI (DP) Regulations 2018more...
Press release regarding EikoVivify Logistics Private Limited subsidiary of Eiko Lifesciences Limited entered in a Container Service Management agreem...more...
EikoVivify Logistics Private Limited subsidiary of Eiko Lifesciences Limited has entered into Container Management Service Agreement dated 1...more...
In continuation to our letter dated 25/11/2024 wherein we had informed that right issue committee of the Company have approved Final Reminder cum For...more...
As of November 2024 31.27% is owned by Indian Promoters and 68.73% by Public. Top five Promoters holding highest number of shares of Eiko Li...more...
Enter Stock
BOARD MEETINGS Company Name : Aadhar Housing Fin Date : 06-05-2025